SSOP

Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore's MinION™ Platform

Retrieved on: 
Monday, September 25, 2023

This cutting-edge technology is set to help clinical laboratories in the field of genetic marker assessment, providing an unprecedented level of accuracy at a competitive pricing structure.

Key Points: 
  • This cutting-edge technology is set to help clinical laboratories in the field of genetic marker assessment, providing an unprecedented level of accuracy at a competitive pricing structure.
  • As a result, many laboratories have relied on molecular techniques such as SSOP or RT-PCR, with lower resolution.
  • NanoTYPE MONO enables labs of all sizes and budgets to enhance their genetic testing capabilities while seamlessly integrating with the compact and environmentally friendly MinION system.
  • To learn more about NanoTYPE MONO and its transformative capabilities for clinical laboratories, please visit www.omixon.com/products/nanotype-mono/

Omixon Launches NanoTYPE MONO™ and MONOall™ RUO, a Singleplex Human Leukocyte Antigen Amplification kit compatible with Oxford Nanopore's MinION™ Platform

Retrieved on: 
Monday, September 25, 2023

This cutting-edge technology is set to help clinical laboratories in the field of genetic marker assessment, providing an unprecedented level of accuracy at a competitive pricing structure.

Key Points: 
  • This cutting-edge technology is set to help clinical laboratories in the field of genetic marker assessment, providing an unprecedented level of accuracy at a competitive pricing structure.
  • As a result, many laboratories have relied on molecular techniques such as SSOP or RT-PCR, with lower resolution.
  • NanoTYPE MONO enables labs of all sizes and budgets to enhance their genetic testing capabilities while seamlessly integrating with the compact and environmentally friendly MinION system.
  • To learn more about NanoTYPE MONO and its transformative capabilities for clinical laboratories, please visit www.omixon.com/products/nanotype-mono/

TI helps maximize EV driving range with SiC gate driver

Retrieved on: 
Tuesday, May 9, 2023

DALLAS, May 9, 2023 /PRNewswire/ -- Texas Instruments (TI) (Nasdaq: TXN), a leader in high-voltage technology, today debuted a highly integrated, functional safety-compliant, isolated gate driver that enables engineers to design more efficient traction inverters and maximize electric vehicle (EV) driving range.

Key Points: 
  • DALLAS, May 9, 2023 /PRNewswire/ -- Texas Instruments (TI) (Nasdaq: TXN), a leader in high-voltage technology, today debuted a highly integrated, functional safety-compliant, isolated gate driver that enables engineers to design more efficient traction inverters and maximize electric vehicle (EV) driving range.
  • "Not only does this new isolated gate driver help enable engineers to maximize driving range, but it also integrates safety features to reduce external components and design complexity.
  • To learn more, read the technical article, " How to Maximize SiC Traction Inverter Efficiency with Real-Time Variable Gate Drive Strength ."
  • Engineers can further reduce components and quickly prototype a more efficient traction inverter system using the SiC EV Traction Inverter Reference Design .

Sinclair Technologies Announces 14-Port Small Cell Antenna of the New SSOP1 Series

Retrieved on: 
Tuesday, November 1, 2022

AURORA, Ontario, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Sinclair Technologies announces its first model of the new SSOP1 Series - a 14-port Small Cell Antenna with multi-band support, including low-band, mid-band, CBRS and LAA.

Key Points: 
  • AURORA, Ontario, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Sinclair Technologies announces its first model of the new SSOP1 Series - a 14-port Small Cell Antenna with multi-band support, including low-band, mid-band, CBRS and LAA.
  • Small Cell Antenna SSOP1 Series is available for immediate order.
  • Sinclair Technologies, a division of Norsat International Inc., is a leading designer and manufacturer of antenna and RF signal conditioning products, systems, and coverage solutions.
  • We have over 70 years of industry-leading expertise in all aspects of antenna and RF signal conditioning design and manufacturing.

DGAP-News: African Energy Chamber Urges United States (US) to Lift South Sudan Oil Sanctions (By NJ Ayuk)

Retrieved on: 
Thursday, September 8, 2022

JOHANNESBURG, South Africa, September 8, 2022 --  By NJ Ayuk, Executive Chairman, African Energy Chamber (www.EnergyChamber.org)

Key Points: 
  • JOHANNESBURG, South Africa, September 8, 2022 -- By NJ Ayuk, Executive Chairman, African Energy Chamber ( www.EnergyChamber.org )
    Four years have passed since the U.S. imposed sanctions on South Sudans oil industry.
  • I have no doubt that the U.S. imposed sanctions on South Sudans energy industry with the people of South Sudan in mind.
  • Now, the African Energy Chamber is calling upon U.S. officials to make another decision with the South Sudanese in mind: Lift the sanctions.
  • That potential will be showcased during South Sudan Oil & Power (SSOP) 2022, The Gateway to East African Energy.

Global L-Carnitine Market Report 2021: Size, Share & Trends Analysis by Process (Bioprocess, Chemical Synthesis), Product (Food & Pharmaceutical Grade, Feed Grade) - ResearchAndMarkets.com

Retrieved on: 
Friday, October 15, 2021

The "L-Carnitine Market Size, Share & Trends Analysis Report by Process (Bioprocess, Chemical Synthesis), by Product (Food & Pharmaceutical Grade, Feed Grade), by Application, by Region, and Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "L-Carnitine Market Size, Share & Trends Analysis Report by Process (Bioprocess, Chemical Synthesis), by Product (Food & Pharmaceutical Grade, Feed Grade), by Application, by Region, and Segment Forecasts, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global L-carnitine market size is expected to reach USD 276.0 million by 2028, expanding at a CAGR of 5.1%.
  • Growing consumer awareness regarding product benefits, along with increasing demand from end-use industries such as pharmaceutical, nutraceutical, and animal feed, is projected to drive the market over the forecast period.
  • L-carnitine and its derivatives are used for numerous applications including male infertility, kidney treatment, cardiovascular diseases, weight reduction, and bone mass.